Bioactive sphingolipids in the modulation of the inflammatory response

Pharmacology and Therapeutics

Volumn 112, Issue 1, 2006, Pages 171-183

  El Alwani, Mazen ^a   Wu, Bill Xingjun ^a   Obeid, Lina M ^a,b   Hannun, Yusuf A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Ceramide; Ceramide 1 phosphate; Cyclooxygenase 2; Inflammation; Sphingosine; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE DERIVATIVE; CERAMIDE KINASE; CYCLOOXYGENASE 2; CYTOKINE; FINGOLIMOD; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROTEIN KINASE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CELL FUNCTION; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; EVIDENCE BASED MEDICINE; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; LIPID METABOLISM; MEDIATOR; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL PROCESSING;

ANIMALS; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; LIPOPOLYSACCHARIDES; PHOSPHOLIPASES A; PROPYLENE GLYCOLS; PROSTAGLANDINS; SPHINGOLIPIDS; SPHINGOSINE;

EID: 33748047499     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.04.004     Document Type: Review

References (174)

1. Abenoza P., and Sibley R.K. Farber's disease: a fine structural study. Ultrastruct Pathol 11 (1987) 397-403
2. Adami M., Coppelli G., Guaita E., Pozzoli C., Menozzi A., Giovannini E., et al. Effects of cyclooxygenase-1 and -2 inhibition on gastric acid secretion and cardiovascular functions in rats. Pharmacology 76 (2005) 84-92
3. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 (2003) 745-756
4. Alemany R., Meyer zu Heringdorf D., van Koppen C.J., and Jakobs K.H. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J Biol Chem 274 (1999) 3994-3999
5. Allende M.L., Sasaki T., Kawai H., Olivera A., Mi Y., van Echten-Deckert G., et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279 (2004) 52487-52492
6. Arch R.H., Gedrich R.W., and Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev 12 (1998) 2821-2830
7. Arend W.P. Interleukin-1 receptor antagonist. Adv Immunol 54 (1993) 167-227
8. Arend W.P., and Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res 2 (2000) 245-248
9. Bachelor M.A., and Bowden G.T. Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3′-untranslated region. J Biol Chem 279 (2004) 42658-42668
10. 2 production in human fibroblasts. J Immunol 145 (1990) 4245-4251
11. Ballou L.R., Chao C.P., Holness M.A., Barker S.C., and Raghow R. Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267 (1992) 20044-20050
12. Bar J., Linke T., Ferlinz K., Neumann U., Schuchman E.H., and Sandhoff K. Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Hum Mutat 17 (2001) 199-209
13. Barber S.A., Detore G., McNally R., and Vogel S.N. Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages. Infect Immun 64 (1996) 3397-3400
14. Beutler B., and Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 7 (1989) 625-655
15. Billich A., Bornancin F., Mechtcheriakova D., Natt F., Huesken D., and Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell Signal 17 (2005) 1203-1217
16. 2. Nature 390 (1997) 622-625
17. Borish L.C., and Steinke J.W. 2. Cytokines and chemokines. J Allergy Clin Immunol 111 (2003) S460-S475
18. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277 (2002) 21453-21457
19. Brinkmann V., and Lynch K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14 (2002) 569-575
20. Brinkmann V., Pinschewer D., Chiba K., and Feng L. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 21 (2000) 49-52
21. Brinkmann V., Pinschewer D.D., Feng L., and Chen S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72 (2001) 764-769
22. Brune K., and Hinz B. The discovery and development of antiinflammatory drugs. Arthritis Rheum 50 (2004) 2391-2399
23. 2 production in human fibroblasts. J Exp Med 174 (1991) 1363-1369
24. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
25. Chang Y., Abe A., and Shayman J.A. Ceramide formation during heat shock: a potential mediator of alpha B-crystallin transcription. Proc Natl Acad Sci U S A 92 (1995) 12275-12279
26. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
27. Chen W., Frank M.E., Jin W., and Wahl S.M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14 (2001) 715-725
28. Cinamon G., Matloubian M., Lesneski M.J., Xu Y., Low C., Lu T., et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 5 (2004) 713-720
29. Cinque B., Di Marzio L., Centi C., Di Rocco C., Riccardi C., and Grazia Cifone M. Sphingolipids and the immune system. Pharmacol Res 47 (2003) 421-437
30. 2. J Lipid Mediat Cell Signal 12 (1995) 83-117
31. Clark J., Vagenas P., Panesar M., and Cope A.P. What does tumour necrosis factor excess do to the immune system long term?. Ann Rheum Dis 64 Suppl. 4 (2005) iv70-iv76
32. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
33. Coroneos E., Martinez M., McKenna S., and Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 270 (1995) 23305-23309
34. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., and Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150 (1993) 353-360
35. Diaz B.L., and Arm J.P. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids 69 (2003) 87-97
36. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
37. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112 (1997) 321S-329S
38. El Bawab S., Bielawska A., and Hannun Y.A. Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J Biol Chem 274 (1999) 27948-27955
39. El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J.J., and Hannun Y.A. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 275 (2000) 21508-21513
40. Ferlinz K., Kopal G., Bernardo K., Linke T., Bar J., Breiden B., et al. Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J Biol Chem 276 (2001) 35352-35360
41. Fu J.Y., Masferrer J.L., Seibert K., Raz A., and Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265 (1990) 16737-16740
42. Gao F., Yue T.L., Shi D.W., Christopher T.A., Lopez B.L., Ohlstein E.H., et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 53 (2002) 414-422
43. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
44. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 270 (1995) 15359-15367
45. Gomez-Munoz A., Kong J., Salh B., and Steinbrecher U.P. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett 539 (2003) 56-60
46. Gomez-Munoz A., Kong J.Y., Parhar K., Wang S.W., Gangoiti P., Gonzalez M., et al. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett 579 (2005) 3744-3750
47. Graeler M., and Goetzl E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J 16 (2002) 1874-1878
48. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186 (1997) 1831-1841
49. Hait N.C., Sarkar S., Le Stunff H., Mikami A., Maceyka M., Milstien S., et al. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J Biol Chem 280 (2005) 29462-29469
50. Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M., et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426 (2003) 803-809
51. Hannun Y.A., and Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277 (2002) 25847-25850
52. 2 activity in rabbit platelets. J Biochem (Tokyo) 122 (1997) 1034-1039
53. 2 alpha-deficient mice are resistant to collagen-induced arthritis. J Exp Med 197 (2003) 1297-1302
54. Hernandez O.M., Discher D.J., Bishopric N.H., and Webster K.A. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circ Res 86 (2000) 198-204
55. 2. Biol Pharm Bull 27 (2004) 1168-1173
56. Hobson J.P., Rosenfeldt H.M., Barak L.S., Olivera A., Poulton S., Caron M.G., et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291 (2001) 1800-1803
57. Hong K.H., Bonventre J.C., O'Leary E., Bonventre J.V., and Lander E.S. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci U S A 98 (2001) 3935-3939
58. Hsu Y.W., Chi K.H., Huang W.C., and Lin W.W. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J Immunol 166 (2001) 5388-5397
59. Huitema K., van den Dikkenberg J., Brouwers J.F., and Holthuis J.C. Identification of a family of animal sphingomyelin synthases. EMBO J 23 (2004) 33-44
60. Ibrahim F.B., Pang S.J., and Melendez A.J. Anaphylatoxin signaling in human neutrophils. A key role for sphingosine kinase. J Biol Chem 279 (2004) 44802-44811
61. Itakura A., Tanaka A., Aioi A., Tonogaito H., and Matsuda H. Ceramide and sphingosine rapidly induce apoptosis of murine mast cells supported by interleukin-3 and stem cell factor. Exp Hematol 30 (2002) 272-278
62. Joseph C.K., Wright S.D., Bornmann W.G., Randolph J.T., Kumar E.R., Bittman R., et al. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biol Chem 269 (1994) 17606-17610
63. 2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41 (2004) 323-335
64. Kawa S., Kimura S., Hakomori S., and Igarashi Y. Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett 420 (1997) 196-200
65. Khan M.A., Kang J., and Steiner T.S. Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology 112 (2004) 651-660
66. Kim M.Y., Linardic C., Obeid L., and Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266 (1991) 484-489
67. Kim J.I., Jo E.J., Lee H.Y., Cha M.S., Min J.K., Choi C.H., et al. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. J Biol Chem 278 (2003) 31731-31736
68. Kitatani K., Akiba S., Hayama M., and Sato T. Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. Arch Biochem Biophys 395 (2001) 208-214
69. 2 expression via generation of reactive oxygen species in tumor necrosis factor-alpha-stimulated mesangial cells. Cell Signal 16 (2004) 967-974
70. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., and Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273 (1998) 23722-23728
71. Kohyama-Koganeya A., Sasamura T., Oshima E., Suzuki E., Nishihara S., Ueda R., et al. Drosophila glucosylceramide synthase: a negative regulator of cell death mediated by proapoptotic factors. J Biol Chem 279 (2004) 35995-36002
72. Kolesnick R., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
73. Kolesnick R.N., and Kronke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 60 (1998) 643-665
74. Kolesnick R.N., Goni F.M., and Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 184 (2000) 285-300
75. 2 and alter its fatty acid specificity. Biochem J 363 (2002) 45-51
76. Koval M., Futerman A.H., and Pagano R.E. Sphingomyelin synthesis in endosomal compartments?. Trends Cell Biol 5 (1995) 148-149 (author reply 149)
77. Kroesen B.J., Jacobs S., Pettus B.J., Sietsma H., Kok J.W., Hannun Y.A., et al. BcR-induced apoptosis involves differential regulation of C16- and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J Biol Chem 278 (2003) 14723-14731
78. Kumagai K., Yasuda S., Okemoto K., Nishijima M., Kobayashi S., and Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 280 (2005) 6488-6495
79. Kveberg L., Bryceson Y., Inngjerdingen M., Rolstad B., and Maghazachi A.A. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur J Immunol 32 (2002) 1856-1864
80. Laulederkind S.J., Bielawska A., Raghow R., Hannun Y.A., and Ballou L.R. Ceramide induces interleukin 6 gene expression in human fibroblasts. J Exp Med 182 (1995) 599-604
81. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267 (1992) 25934-25938
82. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
83. Lee S.Y., Reichlin A., Santana A., Sokol K.A., Nussenzweig M.C., and Choi Y. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7 (1997) 703-713
84. Lightle S., Tosheva R., Lee A., Queen-Baker J., Boyanovsky B., Shedlofsky S., et al. Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Biochem Biophys 419 (2003) 120-128
85. Liu Z.G., Hsu H., Goeddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87 (1996) 565-576
86. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275 (2000) 19513-19520
87. Long J., Darroch P., Wan K.F., Kong K.C., Ktistakis N., Pyne N.J., et al. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem J 391 (2005) 25-32
88. Luberto C., and Hannun Y.A. Sphingolipid metabolism in the regulation of bioactive molecules. Lipids 34 Suppl. (1999) S5-S11
89. Luberto C., Stonehouse M.J., Collins E.A., Marchesini N., El-Bawab S., Vasil A.I., et al. Purification, characterization, and identification of a sphingomyelin synthase from Pseudomonas aeruginosa. PlcH is a multifunctional enzyme. J Biol Chem 278 (2003) 32733-32743
90. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99 (1999) 1685-1691
91. Ma Y., Pitson S., Hercus T., Murphy J., Lopez A., and Woodcock J. Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism. J Biol Chem 280 (2005) 26011-26017
92. Maceyka M., Sankala H., Hait N.C., Le Stunff H., Liu H., Toman R., et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280 (2005) 37118-37129
93. MacKichan M.L., and DeFranco A.L. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog. J Biol Chem 274 (1999) 1767-1775
94. MacKinnon A.C., Buckley A., Chilvers E.R., Rossi A.G., Haslett C., and Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 169 (2002) 6394-6400
95. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
96. Mao C., Xu R., Bielawska A., and Obeid L.M. Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity. J Biol Chem 275 (2000) 6876-6884
97. Mao C., Xu R., Bielawska A., Szulc Z.M., and Obeid L.M. Cloning and characterization of a Saccharomyces cerevisiae alkaline ceramidase with specificity for dihydroceramide. J Biol Chem 275 (2000) 31369-31378
98. Mao C., Xu R., Szulc Z.M., Bielawska A., Galadari S.H., and Obeid L.M. Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276 (2001) 26577-26588
99. Mao C., Xu R., Szulc Z.M., Bielawski J., Becker K.P., Bielawska A., et al. Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J Biol Chem 278 (2003) 31184-31191
100. Marchesini N., and Hannun Y.A. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 82 (2004) 27-44
101. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
102. Medvedev A.E., Blanco J.C., Qureshi N., and Vogel S.N. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. J Biol Chem 274 (1999) 9342-9350
103. 2+ signals, enzyme release, cytokine production, and chemotaxis. J Immunol 173 (2004) 1596-1603
104. Memon R.A., Holleran W.M., Moser A.H., Seki T., Uchida Y., Fuller J., et al. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol 18 (1998) 1257-1265
105. Memon R.A., Holleran W.M., Uchida Y., Moser A.H., Ichikawa S., Hirabayashi Y., et al. Regulation of glycosphingolipid metabolism in liver during the acute phase response. J Biol Chem 274 (1999) 19707-19713
106. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
107. Merrill Jr. A.H., Nixon D.W., and Williams R.D. Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues. J Lipid Res 26 (1985) 617-622
108. Merrill Jr. A.H., and Stevens V.L. Modulation of protein kinase C and diverse cell functions by sphingosine-a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochim Biophys Acta 1010 (1989) 131-139
109. Merrill Jr. A.H., and Wang E. Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s). J Biol Chem 261 (1986) 3764-3769
110. Michel C., van Echten-Deckert G., Rother J., Sandhoff K., Wang E., and Merrill Jr. A.H. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 272 (1997) 22432-22437
111. Mitsutake S., Tani M., Okino N., Mori K., Ichinose S., Omori A., et al. Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem 276 (2001) 26249-26259
112. Mitsutake S., Kim T.J., Inagaki Y., Kato M., Yamashita T., and Igarashi Y. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 279 (2004) 17570-17577
113. 2-mediated bone resorption associated with inflammation. J Exp Med 197 (2003) 1303-1310
114. 2. Nat Immunol 1 (2000) 42-46
115. Nagase T., Uozumi N., Ishii S., Kita Y., Yamamoto H., Ohga E., et al. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 8 (2002) 480-484
116. 2alpha directly and by PKC pathway. Biochem Pharmacol 71 6 (2006) 850-857
117. Nick J.A., Avdi N.J., Young S.K., Lehman L.A., McDonald P.P., Frasch S.C., et al. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103 (1999) 851-858
118. Nick J.A., Young S.K., Brown K.K., Avdi N.J., Arndt P.G., Suratt B.T., et al. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164 (2000) 2151-2159
119. Niiro H., Otsuka T., Izuhara K., Yamaoka K., Ohshima K., Tanabe T., et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89 (1997) 1621-1628
120. Niwa M., Kozawa O., Matsuno H., Kanamori Y., Hara A., and Uematsu T. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sci 66 (2000) 245-256
121. Obeid L.M., Linardic C.M., Karolak L.A., and Hannun Y.A. Programmed cell death induced by ceramide. Science 259 (1993) 1769-1771
122. Olivera A., Rosenfeldt H.M., Bektas M., Wang F., Ishii I., Chun J., et al. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J Biol Chem 278 (2003) 46452-46460
123. Onoe Y., Miyaura C., Kaminakayashiki T., Nagai Y., Noguchi K., Chen Q.R., et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 156 (1996) 758-764
124. Oppenheim J.J. Cytokines: past, present, and future. Int J Hematol 74 (2001) 3-8
125. Perkins N.D. The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci 25 (2000) 434-440
126. Perry R.J., and Ridgway N.D. Molecular mechanisms and regulation of ceramide transport. Biochim Biophys Acta 1734 (2005) 220-234
127. Perry D.K., Carton J., Shah A.K., Meredith F., Uhlinger D.J., and Hannun Y.A. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275 (2000) 9078-9084
128. Pettus B.J., Chalfant C.E., and Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585 (2002) 114-125
129. Pettus B.J., Bielawska A., Spiegel S., Roddy P., Hannun Y.A., and Chalfant C.E. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J Biol Chem 278 (2003) 38206-38213
130. Pettus B.J., Bielawski J., Porcelli A.M., Reames D.L., Johnson K.R., Morrow J., et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J 17 (2003) 1411-1421
131. 2. J Biol Chem 279 (2004) 11320-11326
132. Pettus B.J., Kroesen B.J., Szulc Z.M., Bielawska A., Bielawski J., Hannun Y.A., et al. Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry. Rapid Commun Mass Spectrom 18 (2004) 577-583
133. 2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol Pharmacol 68 (2005) 330-335
134. Pinschewer D.D., Ochsenbein A.F., Odermatt B., Brinkmann V., Hengartner H., and Zinkernagel R.M. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164 (2000) 5761-5770
135. Prieschl E.E., Csonga R., Novotny V., Kikuchi G.E., and Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 190 (1999) 1-8
136. Reinhard C., Shamoon B., Shyamala V., and Williams L.T. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 16 (1997) 1080-1092
137. Riboni L., Viani P., Bassi R., Prinetti A., and Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog Lipid Res 36 (1997) 153-195
138. Romiti E., Meacci E., Tani M., Nuti F., Farnararo M., Ito M., et al. Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem Biophys Res Commun 275 (2000) 746-751
139. Ropert C., Closel M., Chaves A.C., and Gazzinelli R.T. Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol 171 (2003) 1456-1465
140. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
141. Rosenfeldt H.M., Hobson J.P., Milstien S., and Spiegel S. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. Biochem Soc Trans 29 (2001) 836-839
142. 2 activation through a mechanism related to the phospholipase C-initiated signaling pathway in rabbit platelets. J Biochem (Tokyo) 125 (1999) 96-102
143. 2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem 270 (1995) 30749-30754
144. Schlittenhardt D., Schmiedt W., Bonaterra G.A., Metz J., and Kinscherf R. Colocalization of oxidized low-density lipoprotein, caspase-3, cyclooxygenase-2, and macrophage migration inhibitory factor in arteriosclerotic human carotid arteries. Cell Tissue (2005) 1-11
145. Senchenkov A., Litvak D.A., and Cabot M.C. Targeting ceramide metabolism-a strategy for overcoming drug resistance. J Natl Cancer Inst 93 (2001) 347-357
146. Shimizu T., and Wolfe L.S. Arachidonic acid cascade and signal transduction. J Neurochem 55 (1990) 1-15
147. Singer I.I., Tian M., Wickham L.A., Lin J., Matheravidathu S.S., Forrest M.J., et al. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J Immunol 175 (2005) 7151-7161
148. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci U S A 94 (1997) 9792-9796
149. Spiegel S., and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4 (2003) 397-407
150. Sugiura M., Kono K., Liu H., Shimizugawa T., Minekura H., Spiegel S., et al. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem 277 (2002) 23294-23300
151. Takaku K., Sonoshita M., Sasaki N., Uozumi N., Doi Y., Shimizu T., et al. Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J Biol Chem 275 (2000) 34013-34016
152. Tani M., Okino N., Mitsutake S., Tanigawa T., Izu H., and Ito M. Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized. J Biol Chem 275 (2000) 3462-3468
153. Tani M., Okino N., Mori K., Tanigawa T., Izu H., and Ito M. Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases. J Biol Chem 275 (2000) 11229-11234
154. Tani M., Igarashi Y., and Ito M. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu. J Biol Chem 280 (2005) 36592-36600
155. Tani M., Sano T., Ito M., and Igarashi Y. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J Lipid Res 46 (2005) 2458-2467
156. Tartaglia L.A., and Goeddel D.V. Two TNF receptors. Immunol Today 13 (1992) 151-153
157. Tekin D., Xi L., Zhao T., Tejero-Taldo M.I., Atluri S., and Kukreja R.C. Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart. Am J Physiol Heart Circ Physiol 281 (2001) H523-H532
158. Underwood D.C., Osborn R.R., Kotzer C.J., Adams J.L., Lee J.C., Webb E.F., et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 293 (2000) 281-288
159. Vincenti M.P., and Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4 (2002) 157-164
160. Wahl S.M., and Chen W. Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 7 (2005) 62-68
161. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 10 (2003) 45-65
162. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17 (1999) 331-367
163. Won J.S., Im Y.B., Khan M., Singh A.K., and Singh I. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J Neurochem 88 (2004) 583-593
164. Wright S.D., and Kolesnick R.N. Does endotoxin stimulate cells by mimicking ceramide?. Immunol Today 16 (1995) 297-302
165. Wright S.C., Zheng H., and Zhong J. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J 10 (1996) 325-332
166. Wu W., Mosteller R.D., and Broek D. Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol Cell Biol 24 (2004) 7359-7369
167. Xia P., Gamble J.R., Rye K.A., Wang L., Hii C.S., Cockerill P., et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci U S A 95 (1998) 14196-14201
168. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., and Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 88 (1991) 2692-2696
169. Yedgar S., Lichtenberg D., and Schnitzer E. Inhibition of phospholipase A(2) as a therapeutic target. Biochim Biophys Acta 1488 (2000) 182-187
170. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7 (1997) 715-725
171. Yoshimura Y., Okino N., Tani M., and Ito M. Molecular cloning and characterization of a secretory neutral ceramidase of Drosophila melanogaster. J Biochem (Tokyo) 132 (2002) 229-236
172. Yoshimura Y., Tani M., Okino N., Iida H., and Ito M. Molecular cloning and functional analysis of zebrafish neutral ceramidase. J Biol Chem 279 (2004) 44012-44022
173. Yuasa T., Ohno S., Kehrl J.H., and Kyriakis J.M. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 273 (1998) 22681-22692
174. Zemann B., Kinzel B., Muller M., Reuschel R., Mechtcheriakova D., Urtz N., et al. Sphingosine kinase type 2 is essential for lymphodepletion induced by the immunomodulatory drug FTY720. Blood 107 4 (2005) 1454-1458